17 completed. 17 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 17 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Cholera: new trials by email Literature Review of Cholera trials Research Report on Cholera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera VR-AD-1005, Placebo - Cholera | Phase 2 | Completed | Hunazine Biotech S.L. | 150 | 2024-02-11 | 2026-06-02 |
| Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea Next Generation ORS (oral rehydration solution) (including placebo, Current standard control ORS (oral rehydration solution) - Diarrhea, Cholera | Phase 2 / Phase 3 | Completed | University of Florida | 396 | 2023-08-21 | 2026-04-14 |
| Single Dose Azithromycin to Prevent Cholera in Children Azithromycin, Placebo - Cholera | Phase 2 | Completed | Massachusetts General Hospital | 2475 | 2021-10-31 | 2026-08-07 |
| Cholera Anti-Secretory Treatment Trial iOWH032, Placebo, V. cholerae Challenge - Cholera | Phase 2 | Completed | PATH | 47 | 2019-11-04 | 2021-03-25 |
| Extended Dose Intervals With Oral Cholera Vaccine in Cameroon killed whole cell oral cholera vaccine - Adverse Reaction to Cholera Vaccine, Cholera Vaccination Reaction | Phase 2 | Completed | Johns Hopkins Bloomberg School of Public Health | 181 | 2018-10-23 | 2022-10-05 |
| Immunologic Responses to a Live Attenuated Oral Cholera Vaccine Vaxchora - Cholera | Phase 2 | Completed | Emory University | 34 | 2017-08-29 | 2026-02-13 |
| Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine HL-OCV, Shanchol - Cholera | Phase 1 / Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 840 | 2016-07-01 | 2018-11-02 |
| Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine Cholvax, Shanchol - Cholera | Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 2052 | 2016-04-01 | 2017-06-16 |
| PXVX0200 (CVD103-HgR) vs Shanchol in Mali PXVX0200 10E8, PXVX0200 10E9, Placebo - Cholera | Phase 2 | Completed | University of Maryland, Baltimore | 150 | 2014-07-01 | 2019-09-26 |
| Slow Versus Rapid Rehydration of Severely Malnourished Children Rapid dehydration, Slow rehydration - Diarrhea | Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 208 | 2011-05-01 | 2014-08-21 |
| Study of Alternative Vaccination Schedule of Oral Cholera Vaccine Modified killed oral cholera vaccine at 14 day interval, Modified killed oral cholera vaccine at 28 day interval - Cholera, Diarrhoea | Phase 2 | Completed | International Vaccine Institute | 386 | 2010-12-01 | 2013-09-25 |
| Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults CholeraGarde®, Placebo - Cholera, Vibrio Infections | Phase 2 | Completed | International Vaccine Institute | 32 | 2010-07-01 | 2012-03-30 |
| Studies of Immune Responses to Orally Administered Vaccines in Developing Country Placebo, Control, Zinc Sulphate - Cholera, Typhoid | Phase 1 / Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 1016 | 2008-02-01 | 2011-07-12 |
| Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine Killed bivalent whole cell oral cholera vaccine, Heat Killed E. coli Placebo - Cholera, Diarrhea | Phase 2 | Completed | International Vaccine Institute | 160 | 2007-06-01 | 2009-12-07 |
| Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata killed whole cell oral cholera vaccine, Heat Killed E. coli - Cholera | Phase 2 | Completed | International Vaccine Institute | 200 | 2005-08-01 | 2008-07-04 |
| Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine killed oral cholera vaccine - Cholera | Phase 2 | Completed | International Vaccine Institute | 150 | 2005-05-01 | 2006-11-10 |
| Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in Adults Benefiber, Benefiber with ORS, the reduced-osmolarity WHO-ORS without added Benefiber - Cholera | Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 195 | 2003-05-01 | 2008-05-06 |
Diarrhea (5) · Vibrio Infections (3) · Communicable Diseases (1) · Dehydration (1) · Malnutrition (1) · Osteoarthritis (1) · Typhoid Fever (1)
Bacterial Infections (17) · Bacterial Infections and Mycoses (17) · Gram-Negative Bacterial Infections (17) · Infections (17) · Vibrio Infections (14) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (5) · Signs and Symptoms, Digestive (5) · Pathologic Processes (2) · Arthritis (1) · Disease Attributes (1) · Enterobacteriaceae Infections (1) · Joint Diseases (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1)
shanchol (4) · Albendazole (1) · Anti-Bacterial Agents (1) · Arsenic (1) · Azithromycin (1) · Calcium (1) · IOWH-032 (1) · ORALIT (1) · Peru 15 (1) · Vaxchora (1) · World Health Organization oral rehydration solution (1) · Zinc Sulfate (1) · secnidazole (1)
International Centre for Diarrhoeal Disease Research, Bangladesh (5) · International Vaccine Institute (5) · Emory University (1) · Hunazine Biotech S.L. (1) · Johns Hopkins Bloomberg School of Public Health (1) · Massachusetts General Hospital (1) · PATH (1) · University of Florida (1) · University of Maryland, Baltimore (1)
Bangladesh (8) · India (3) · United States (2) · Cameroon (1) · Mali (1) · Thailand (1) · Vietnam (1)
Firdausi Qadri, Dr. (2) · Dang Duc Anh, PhD (1) · David Sack, MD (1) · Dipika Sur, MD, DPH (1) · Firdausi Qadri, PhD (1) · Jason B Harris, MD, MPH (1) · Milagritos D Tapia, MD (1) · Nadine Rouphael, MD (1) · Sam Cheng, MD. PhD (1) · Samba O Sow, MD, MS (1) · Sujit K Bhattacharya (1) · Sujit K Bhatttacharya, MD (1) · Winai Ratanasuwan, MD, MPH (1)
PMID 22461716, PMID 16760521, PMID 17055622, PMID 18398491, PMID 18769066, PMID 19761838, PMID 21907255, PMID 24101640, PMID 29021299, PMID 34218960, PMID 34478460, PMID 34793441
R01AI137127 (1), R01HD102540 (1), R21AI169282 (1)